These observations suggest a contribution of SphKs/S1P/S1PRs signaling in metastatic triple-negative breast cancer and that S1P signaling may be a therapeutic target in triple-negative breast cancer [213]. Here, MBTPS1 is linked to triple-negative breast carcinoma.